Lombard Medical Technologies PLC Notice of Results (7708J)
July 22 2013 - 2:00AM
UK Regulatory
TIDMLMT
RNS Number : 7708J
Lombard Medical Technologies PLC
22 July 2013
Lombard Medical Technologies PLC
("Lombard Medical" or "Company")
Notice of Results
London, UK, 22 July 2013 - Lombard Medical Technologies PLC
(AIM:LMT), the specialist medical technology company focussed on
innovative vascular products, will announce its interim results for
the six months ended 30 June 2013 on Thursday 29 August 2013.
-Ends-
For further information:
Lombard Medical Technologies PLC Tel: 01235 750 800
Simon Hubbert, Chief Executive Officer
Ian Ardill, Chief Financial Officer
Canaccord Genuity Limited Tel: 020 7523 8000
Lucy Tilley / Tim Redfern / Henry Fitzgerald
O'Connor / Dr Julian Feneley
FTI Consulting Tel: 020 7831 3113
Simon Conway / Susan Stuart / Victoria
Foster Mitchell
About Lombard Medical
Lombard Medical Technologies PLC (AIM: LMT), is a medical device
company focused on device solutions for the $1.2 billion dollar per
annum abdominal aortic aneurysm (AAA) repair market. AAAs are a
balloon-like enlargement of the aorta which, if left untreated, may
rupture and cause death. Approximately 4.5 million people are
living with AAAs in the developed world and each year 600,000 new
cases are diagnosed. The market for endovascular stent grafts for
this application is expected to grow to $1.6 billion by 2015. The
Company's lead product, Aorfix(TM), is an endovascular stent graft
which has been specifically designed to solve the problems that
exist in treating complex tortuous anatomy which is often present
in advanced AAA disease. Aorfix(TM) is currently being
commercialised in the EU, and has been approved by the FDA in the
US, the first AAA stent graft not of US origin to gain FDA
approval. The Company intends to launch Aorfix(TM) with Aorflex(TM)
in the US in H2 2013; a coordinated launch event will take place at
the VEITH symposium in New York City in November 2013.
The Company is headquartered in Oxfordshire, with operations in
Ayrshire and Phoenix, USA.
Further background on the Company can be found at
www.lombardmedical.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORDMGMNKLRGFZM
Lombard Medical Technologies (LSE:LMT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Lombard Medical Technologies (LSE:LMT)
Historical Stock Chart
From Sep 2023 to Sep 2024